A detailed history of Advisory Services Network, LLC transactions in Incyte Corp stock. As of the latest transaction made, Advisory Services Network, LLC holds 39,925 shares of INCY stock, worth $3.03 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
39,925
Previous 39,925 -0.0%
Holding current value
$3.03 Million
Previous $2.42 Million 9.05%
% of portfolio
0.05%
Previous 0.05%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$51.18 - $63.75 $353,449 - $440,257
6,906 Added 20.92%
39,925 $2.42 Million
Q1 2024

May 06, 2024

BUY
$56.55 - $66.59 $1.82 Million - $2.15 Million
32,251 Added 4199.35%
33,019 $1.88 Million
Q4 2023

Feb 09, 2024

BUY
$52.16 - $64.19 $40,058 - $49,297
768 New
768 $48,000
Q1 2023

May 17, 2023

SELL
$70.23 - $86.01 $351 - $430
-5 Reduced 1.21%
408 $29,000
Q4 2022

Feb 13, 2023

BUY
$67.18 - $84.11 $27,745 - $34,737
413 New
413 $33,000
Q3 2021

Nov 05, 2021

SELL
$68.67 - $84.02 $28,841 - $35,288
-420 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$79.87 - $87.53 $33,545 - $36,762
420 New
420 $35,000
Q1 2021

May 24, 2021

SELL
$76.02 - $100.5 $12,923 - $17,085
-170 Closed
0 $0
Q4 2020

Feb 09, 2021

SELL
$80.74 - $97.7 $37,867 - $45,821
-469 Reduced 73.4%
170 $15,000
Q3 2020

Nov 16, 2020

BUY
$85.07 - $109.69 $54,359 - $70,091
639 New
639 $57,000
Q2 2020

Aug 10, 2020

SELL
$74.18 - $108.93 $40,576 - $59,584
-547 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$63.18 - $85.97 $1.03 Million - $1.4 Million
-16,260 Reduced 96.75%
547 $40,000
Q4 2019

Feb 04, 2020

BUY
$73.04 - $95.72 $1.22 Million - $1.6 Million
16,727 Added 20908.75%
16,807 $1.47 Million
Q2 2019

Aug 01, 2019

BUY
$73.52 - $88.7 $4,411 - $5,322
60 Added 300.0%
80 $0
Q4 2018

Feb 15, 2019

BUY
$58.5 - $69.94 $1,170 - $1,398
20 New
20 $1,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.